Bausch + Lomb Corp (BLCO) Peer Comparison

$17.13

$-0.12 (-0.70%)

As on 27-Aug-2026 16:00EDT

Market cap

$6,233 Mln

Revenue (TTM)

$5,319 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Edit

	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)	Profound Medical (PROF)
Market cap ($ Mln)	6,233	337	248
Revenue ($ Mln)	5,319	302	19
Net Profit ($ Mln)	-171.00	14.50	-32.65
Net Margin (%)	-3.21	4.81	-171.72
RoE (%)	-2.79	9.78	-46.38
Price to Earnings	--	23.92	--
Price-To-Book	0.98	2.26	4.88

Cashflow
Ratios

Cashflow ($ Mln)

	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)	Profound Medical (PROF)
Cash From Operating Activities	283.00	51.92	-38.88
Cash Flow from Investing Activities	-455.00	-50.17	-0.25
Cash from Financing Activities	225.00	-5.79	41.86
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)	Profound Medical (PROF)
ROCE (%)	-3.10	10.10	-53.15
ROE (%)	-2.79	9.78	-46.38
ROA (%)	-1.09	6.12	-51.46
EBIT Margin (%)	6.22	7.75	-177.13
Net Margin (%)	-3.21	4.81	-171.72
Cash Profit Margin (%)	0.00	0.00	0.00

Growth Ratios

	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)	Profound Medical (PROF)
Revenue Growth (%)	8.75	25.21	62.18
EBIT Growth (%)	967.74	31.75	22.64
Net Profit Growth (%)	37.36	3.73	20.60
EPS Growth (%)	37.71	5.67	32.81
Book Value Growth (%)	-1.94	2.97	4.83

Valuation Ratios

	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)	Profound Medical (PROF)
Price / Earnings	-16.81	19.98	-5.58
Price / Book Value	0.94	2.11	2.66
Dividend Yield (%)	--	--	--
EV/EBITDA	20.64	5.83	-4.02
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)	Profound Medical (PROF)
Debt to Equity	0.80	0.04	0.00
Short term debt to equity ratio	0.01	0.01	0.09
Current Ratio	1.55	1.13	6.45
Quick Ratio	1.02	1.02	5.31
Interest Coverage	0.84	15.88	--

Operating Efficiency Ratios

	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)	Profound Medical (PROF)
Debtors to sales (%)	21.81	10.69	50.57
Asset Turnover	0.34	1.27	0.30
Receivable days	80.45	34.12	188.50
Inventory Days	159.20	14.90	651.71
Payable days	61.48	34.46	131.90
Cash Conversion Cycle	178.17	14.56	708.30

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly